P Thomas

Hannover Medical School, Hanover, Lower Saxony, Germany

Are you P Thomas?

Claim your profile

Publications (1)3.18 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many research groups have developed targeted vectors for gene therapy based on Moloney murine leukemia virus (MoMLV). Despite proper binding of the targeted vector to the target molecule, little or no infectivity of human cells expressing the target molecule has been achieved in most studies. One of the reasons for this lack of infectivity may be steric hindrance within the targeted envelope glycoprotein (Env), impeding the conformational changes required for fusion and infection. Here, attempts were made to solve this problem by mutating key residues within Env of two targeted MoMLV-based vectors, MoMLV-E-Sel and MoMLV-FBP. Selection of key residues was based on an Env with reduced threshold for fusion, that of the CD4-independent human immunodeficiency virus type 2 isolate ROD/B. It was shown here that vectors bearing MoMLV-FBP Env with a V512M substitution had higher titres and faster kinetics of entry than vectors bearing parental targeted Env proteins. This could be due to the partial release of steric constraints that result in an Env with a reduced threshold for fusion.
    Full-text · Article · Oct 2005 · Journal of General Virology

Publication Stats

3.18 Total Impact Points

Top Journals


  • 2005
    • Hannover Medical School
      Hanover, Lower Saxony, Germany